News

Deal Announcements

Intarcia Therapeutics Nets New VC Debt Funding

Friday, August 26, 2011 5:38:00 AM PDT | VentureDeal Staff
   Hayward, California  --  Pharmaceutical company Intarcia Therapeutics has garnered $13.3 million in new venture capital debt financing according to an SEC regulatory filing.

Intarcia is developing therapies for the treatment of poorly controlled immunological, cancer and infectious diseases.

Investors in the financing were not disclosed, nor was how the company intends to use the funding proceeds.

Intarcia is still seeking an additional $3.7 million in financing, according to the filing.

Email Page  Email Page | Print Page Print Page

Free Trial

Want unlimited access to the complete database with thousands of technology companies, VCs and transactions for only $25 per month?

Start your Free 14 Day Trial now – no obligation or credit card required.

Free 14 day trial. No Obligation. Click to Register.
Venturedeal Twitter Venturedeal Facebook Venturedeal Linkedin


PCI - Level1